$HilleVax (HLVX.US)$ 10% Shareholder Frazier Life Sciences X, L.P. purchased 8,850 shares of common stock on Apr 4, 2024 at an average price of $14.5 for a total value of $128.33K.
This transaction involves other related parties: FHMLS X, L.P., FHMLS X, L.L.C., Topper James N and Heron Patrick J.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.